L.J. Altfest & Co’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,050
| Closed | -$284K | – | 335 |
|
|
2025
Q1 | $284K | Buy |
+1,050
| New | +$284K | 0.04% | 279 |
|
|
2024
Q3 | – | Sell |
-2,112
| Closed | -$513K | – | 334 |
|
|
2024
Q2 | $513K | Buy |
2,112
+12
| +0.6% | +$2.92K | 0.07% | 192 |
|
|
2024
Q1 | $314K | Buy |
2,100
+27
| +1% | +$4.04K | 0.04% | 254 |
|
|
2023
Q4 | $397K | Buy |
2,073
+475
| +30% | +$91K | 0.06% | 214 |
|
|
2023
Q3 | $283K | Buy |
1,598
+489
| +44% | +$86.6K | 0.04% | 247 |
|
|
2023
Q2 | $211K | Sell |
1,109
-18
| -2% | -$3.43K | 0.03% | 278 |
|
|
2023
Q1 | $226K | Sell |
1,127
-11
| -1% | -$2.21K | 0.04% | 253 |
|
|
2022
Q4 | $270K | Sell |
1,138
-38
| -3% | -$9.02K | 0.04% | 221 |
|
|
2022
Q3 | $235K | Sell |
1,176
-411
| -26% | -$82.1K | 0.04% | 239 |
|
|
2022
Q2 | $231K | Sell |
1,587
-18
| -1% | -$2.62K | 0.04% | 227 |
|
|
2022
Q1 | $262K | Buy |
+1,605
| New | +$262K | 0.05% | 220 |
|